Ned Rosinsky, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 96 Harry S Truman Drive, Suite 250, Upper Marlboro, MD 20774 Phone: 301-324-0600 Fax: 301-324-5009 |
Dr. Frederick Y. Wu, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 202-419-6950 Fax: 202-419-6951 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Scientists have modeled a system that may be used to control mosquitoes and the diseases they transmit, without the use of pesticides. In the proposed system, mosquitoes are engineered to carry two genes. The first gene causes males to transmit a toxin to females through their semen. The second gene, when expressed in females, makes them immune to this toxin.
Iowa Republican Sen. Chuck Grassley, the ranking member of the Senate Finance Committee, says a Senate health bill will not include end-of-life care consultation, as the dispute over the provision continues to swirl.
Top medical research organisations are calling on the European Union for urgent reforms to the way clinical trials are regulated across the continent.
› Verified 8 days ago